To further identify the potential underlying mechanisms by which hepatic deletion of HuR promotes NAFLD progression, we examined H19 expression in the livers of human NASH patients and WDSW-induced NASH mouse models. Here, ELAVL1 is linked to metabolic dysfunction-associated steatohepatitis.